{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "61434-071",
      "generic_name": "ansuvimab-zykl",
      "labeler_name": "Catalent Indiana, LLC",
      "active_ingredients": [
        {
          "name": "ANSUVIMAB",
          "strength": "400 mg/1"
        }
      ],
      "finished": false,
      "packaging": [
        {
          "package_ndc": "61434-071-00",
          "description": "224 VIAL, GLASS in 1 CASE (61434-071-00)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS",
          "marketing_start_date": "21-DEC-20"
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {},
      "marketing_category": "DRUG FOR FURTHER PROCESSING",
      "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
      "spl_id": "3c67a5d9-599a-62b8-e063-6294a90adff3",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "marketing_start_date": "20201221",
      "product_id": "61434-071_3c67a5d9-599a-62b8-e063-6294a90adff3",
      "brand_name_base": null
    }
  ]
}